Your browser doesn't support javascript.
loading
MELK Inhibition in Diffuse Intrinsic Pontine Glioma.
Meel, Michaël H; de Gooijer, Mark C; Guillén Navarro, Miriam; Waranecki, Piotr; Breur, Marjolein; Buil, Levi C M; Wedekind, Laurine E; Twisk, Jos W R; Koster, Jan; Hashizume, Rintaro; Raabe, Eric H; Montero Carcaboso, Angel; Bugiani, Marianna; van Tellingen, Olaf; van Vuurden, Dannis G; Kaspers, Gertjan J L; Hulleman, Esther.
Afiliación
  • Meel MH; Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.
  • de Gooijer MC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Guillén Navarro M; Division of Pharmacology/Mouse Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Waranecki P; Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.
  • Breur M; Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.
  • Buil LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Wedekind LE; Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.
  • Twisk JWR; Division of Pharmacology/Mouse Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Koster J; Department of Neurosurgery, Neuro-oncology Research Group, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.
  • Hashizume R; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands.
  • Raabe EH; Department of Oncogenomics Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • Montero Carcaboso A; Departments of Neurological Surgery, Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Bugiani M; Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • van Tellingen O; Preclinical Therapeutics and Drug Delivery Research Program, Department of Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • van Vuurden DG; Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.
  • Kaspers GJL; Division of Pharmacology/Mouse Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Hulleman E; Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.
Clin Cancer Res ; 24(22): 5645-5657, 2018 11 15.
Article en En | MEDLINE | ID: mdl-30061363
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Serina-Treonina Quinasas / Neoplasias del Tronco Encefálico / Inhibidores de Proteínas Quinasas / Glioma Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Serina-Treonina Quinasas / Neoplasias del Tronco Encefálico / Inhibidores de Proteínas Quinasas / Glioma Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos